Zobrazeno 1 - 10
of 109
pro vyhledávání: '"Nazila, Yousefi"'
Publikováno v:
Journal of Innovation & Knowledge, Vol 9, Iss 3, Pp 100503- (2024)
As the expenses associated with new product development (NPD) continue to rise, intellectual capital (IC) plays a critical yet understudied role in influencing NPD performance (NPDP). To address this, we present a comprehensive theoretical framework
Externí odkaz:
https://doaj.org/article/59b3a14dc3324f6b98cbeadf3944e8b9
Autor:
Nazila Yousefi, Hesam Noqani, Ghader Mohammadnezhad, MohammadJavad Foroughi, Farzad Peiravian
Publikováno v:
Journal of Pharmaceutical Care, Vol 12, Iss 1 (2024)
Background The cosmetics business is one of the most profitable and advanced global trade sectors, and academic and industrial investments have expanded to provide high-quality products to the right consumers. Thus, this cross-sectional survey ass
Externí odkaz:
https://doaj.org/article/ab2bc0b6e7894bb9aea2bd954b795478
Publikováno v:
BMC Pulmonary Medicine, Vol 23, Iss 1, Pp 1-8 (2023)
Abstract Background A heavy financial burden is imposed on patients suffering from chronic diseases due to medicine out-of-pocket payments. Objectives This study focuses on assessing the affordability of medications used for chronic respiratory disea
Externí odkaz:
https://doaj.org/article/55cc5cba7bf14479bc0eeb068ffb7174
Autor:
Nazila Yousefi, Behniya Azadmehr, Seyyed Ali Hashemi, Mohammadhossein Motevali Khameneh, Farzad Peiravian
Publikováno v:
Rāhburdhā-yi Mudīriyyat dar Niẓām-i Salāmat, Vol 8, Iss 2, Pp 161-175 (2023)
Background: Biosimilars can be considered generic versions of branded biologic medicines. Substituting branded biologic medicines with biosimilars is important to reduce medication costs. In addition to reducing drug costs, the domestic production of
Externí odkaz:
https://doaj.org/article/0a55eac738a1459096e3513bd22835e8
Autor:
Nazila Yousefi, Farzad Peiravian
Publikováno v:
Journal of Pharmacoeconomics and Pharmaceutical Management, Vol 5 (2023)
The 2nd Euro-Asian congress of pharmacoepidemiology (EAPEC 2019) was held in Tehran, Iran, November 13rd–15th, 2019[1]. The congress was organized by the school of pharmacy of Shahid Beheshti University of Medical Sciences (SMBU), and supported by
Externí odkaz:
https://doaj.org/article/aef28b0e3c7d4dd3b1f367c03bb652e4
Publikováno v:
Exploratory Research in Clinical and Social Pharmacy, Vol 11, Iss , Pp 100301- (2023)
Background: The prevalence of common cold can impose financial burden on the healthcare systems, despite its simple and self-limiting symptoms. Objective: This study examines the behavior of patients suffering from symptoms of the common cold and exp
Externí odkaz:
https://doaj.org/article/9f0ec9bf8a9b4442808d8930e842ec82
Publikováno v:
Cost Effectiveness and Resource Allocation, Vol 20, Iss 1, Pp 1-14 (2022)
Abstract Objectives This study was aimed to systematically review published economic studies to determine whether dapagliflozin, a sodium-glucose co-transporter inhibitor, plus standard care therapy (SCT) is cost-effective in heart failure with reduc
Externí odkaz:
https://doaj.org/article/545a6e09cfcc4cedba140878530e47c2
Autor:
Fatemeh Babaie, Mohammad Hossein Motevalli, Gholamhossein Mehralian, Farzad Peiravian, Nazila Yousefi
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Introduction: Governments apply different pricing policies to ensure public accessibility, availability, and affordability of medicines. In this way, external reference pricing (ERP) because of its easy implementation is used widely across countries.
Externí odkaz:
https://doaj.org/article/04817beed2fb47f1b2c85814d3d7e975
Publikováno v:
Rāhburdhā-yi Mudīriyyat dar Niẓām-i Salāmat, Vol 6, Iss 4, Pp 353-362 (2022)
Background: Supporting domestic production, by assuming its effect on the increase of accessibility, has been acknowledged as one of the main pharmaceutical policies from two dimensions of better provision of the drugs in the market and the increase
Externí odkaz:
https://doaj.org/article/619d2fbc5a3641f1a8d6640a0df046e2
Publikováno v:
Journal of Pharmaceutical Policy and Practice, Vol 15, Iss 1 (2022)
Background Pharmaceutical advertising is not only considered a key factor in the successful launch of pharmaceutical products, but is also an important source of public health information with a significant impact on consumer choice and behavior. Now
Externí odkaz:
https://doaj.org/article/d7e0f14154bd410d852ddebb34a6fb8b